202 related articles for article (PubMed ID: 18216289)
1. Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons.
Lau T; Horschitz S; Berger S; Bartsch D; Schloss P
FASEB J; 2008 Jun; 22(6):1702-14. PubMed ID: 18216289
[TBL] [Abstract][Full Text] [Related]
2. Monitoring mouse serotonin transporter internalization in stem cell-derived serotonergic neurons by confocal laser scanning microscopy.
Lau T; Horschitz S; Bartsch D; Schloss P
Neurochem Int; 2009; 54(3-4):271-6. PubMed ID: 19121357
[TBL] [Abstract][Full Text] [Related]
3. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.
Kittler K; Lau T; Schloss P
Eur J Pharmacol; 2010 Mar; 629(1-3):63-7. PubMed ID: 20006597
[TBL] [Abstract][Full Text] [Related]
4. The allosteric citalopram binding site differentially interferes with neuronal firing rate and SERT trafficking in serotonergic neurons.
Matthäus F; Haddjeri N; Sánchez C; Martí Y; Bahri S; Rovera R; Schloss P; Lau T
Eur Neuropsychopharmacol; 2016 Nov; 26(11):1806-1817. PubMed ID: 27665061
[TBL] [Abstract][Full Text] [Related]
5. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.
Mnie-Filali O; Lau T; Matthaeus F; Abrial E; Delcourte S; El Mansari M; Pershon A; Schloss P; Sánchez C; Haddjeri N
CNS Neurosci Ther; 2016 Aug; 22(8):691-9. PubMed ID: 27171685
[TBL] [Abstract][Full Text] [Related]
6. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
Guiard BP; Mansari ME; Murphy DL; Blier P
Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-induced down-regulation of cell surface serotonin transporter.
Jørgensen TN; Christensen PM; Gether U
Neurochem Int; 2014 Jul; 73():107-12. PubMed ID: 24462583
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
[TBL] [Abstract][Full Text] [Related]
9. NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.
Lelas S; Li YW; Wallace-Boone TL; Taber MT; Newton AE; Pieschl RL; Davis CD; Molski TF; Newberry KS; Parker MF; Gillman KW; Bronson JJ; Macor JE; Lodge NJ
Neuropharmacology; 2013 Oct; 73():232-40. PubMed ID: 23770339
[TBL] [Abstract][Full Text] [Related]
10. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain.
Thakker DR; Natt F; Hüsken D; van der Putten H; Maier R; Hoyer D; Cryan JF
Mol Psychiatry; 2005 Aug; 10(8):782-9, 714. PubMed ID: 15940298
[TBL] [Abstract][Full Text] [Related]
11. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
[TBL] [Abstract][Full Text] [Related]
12. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
[TBL] [Abstract][Full Text] [Related]
13. FLUOXETINE modifies the expression of serotonergic markers in a differentiation-dependent fashion in the mesencephalic neural cell line A1 mes c-myc.
Di Lieto A; Leo D; Volpicelli F; di Porzio U; Colucci-D'Amato L
Brain Res; 2007 Apr; 1143():1-10. PubMed ID: 17321503
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor.
Horschitz S; Hummerich R; Schloss P
Neuroreport; 2001 Jul; 12(10):2181-4. PubMed ID: 11447330
[TBL] [Abstract][Full Text] [Related]
15. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques.
Lu NZ; Eshleman AJ; Janowsky A; Bethea CL
Mol Psychiatry; 2003 Mar; 8(3):353-60. PubMed ID: 12660809
[TBL] [Abstract][Full Text] [Related]
16. Neonatal fluoxetine exposure modulates serotonergic neurotransmission and disturb inhibitory action of serotonin on food intake.
Pinheiro IL; da Silva AI; Reginato A; da Silva Filho RC; Galindo LCM; Matos RJB; de Souza Ferraz JC; Toscano Meneses da Silva Castro AE; Milanski Ferreira M; Manhães de Castro R; de Souza SL
Behav Brain Res; 2019 Jan; 357-358():65-70. PubMed ID: 28756214
[TBL] [Abstract][Full Text] [Related]
17. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
[TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
Schrantee A; Lucassen PJ; Booij J; Reneman L
Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
[TBL] [Abstract][Full Text] [Related]
19. In vivo investigation of escitalopram's allosteric site on the serotonin transporter.
Murray KE; Ressler KJ; Owens MJ
Pharmacol Biochem Behav; 2016 Feb; 141():50-7. PubMed ID: 26621784
[TBL] [Abstract][Full Text] [Related]
20. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
